CAJ | 학술논문

目的：分析软组织肉瘤手术、放射治疗、化疗的临床疗效及影响其预后的因素。方法回顾性分析我院2004年7月-2012年7月收治12例软组织肉瘤患者的临床治疗及随访情况。结果全部病例3，5，8年生存率分别为78.5%，42.8%，21.4%。临床分期是决定预后的主要因素，分期越早，治疗效果越好。结论综合治疗可以延长软组织肉瘤患者的生命，临床分期是决定预后的主要因素，对患者生存期有显著影响。
목적：분석연조직육류수술、방사치료、화료적림상료효급영향기예후적인소。방법회고성분석아원2004년7월-2012년7월수치12례연조직육류환자적림상치료급수방정황。결과전부병례3，5，8년생존솔분별위78.5%，42.8%，21.4%。림상분기시결정예후적주요인소，분기월조，치료효과월호。결론종합치료가이연장연조직육류환자적생명，림상분기시결정예후적주요인소，대환자생존기유현저영향。
Objective To study the effectiveness of surgery, radiotherapy and chemotherapy in the clinical feasibility and prognostic factors of soft tissue sarcoma. Methods Twelve soft tissue sarcoma patients admitted from 2007 to 2012 were treated by the clinical data together with the effectiveness of different stages of clinical , surgical treatment, radiotherapy and chemotherapy. Results The overall 3-year, 5-year and 8-year survival were 78.5%, 42.8%and 21.4%, respectively. Conclusion stage is the predominant determining factor in prognosis. Early in stages, better the therapeutic effect.